In hepatocellular carcinoma (HCC), FABP9 co-amplifies with other FABP family members (e.g., FABP4, FABP5), which may synergistically promote lipid metabolic reprogramming and tumor progression. This evidence concerns the gene FABP4 and neoplasm.